(RJF) Raymond James Financial - Overview
Stock: Investments, Banking, Brokerage, Planning, Management
| Risk 5d forecast | |
|---|---|
| Volatility | 28.2% |
| Relative Tail Risk | -2.13% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.29 |
| Alpha | -9.76 |
| Character TTM | |
|---|---|
| Beta | 1.006 |
| Beta Downside | 1.144 |
| Drawdowns 3y | |
|---|---|
| Max DD | 28.12% |
| CAGR/Max DD | 0.64 |
EPS (Earnings per Share)
Revenue
Description: RJF Raymond James Financial March 05, 2026
Raymond James Financial, Inc. (RJF) is a diversified financial services company operating in the United States, Canada, and Europe. It provides services to individuals, corporations, and municipalities.
The companys Private Client Group offers financial planning, investment advisory, and securities transaction services. This segment is characteristic of wealth management firms, which focus on personalized financial solutions for individual clients.
The Capital Markets segment handles investment banking services, including equity and debt underwriting and M&A advisory, alongside fixed income and equity brokerage. Investment banking is a key component of the financial sector, facilitating capital raising and corporate transactions.
Asset Management provides portfolio management and related administrative services to retail and institutional clients. This business model relies on generating fees from assets under management (AUM).
The Bank segment offers various loan types, including securities-based and commercial real estate, along with FDIC-insured deposit accounts. This segment operates as a traditional bank, providing lending and deposit services.
The Other segment includes private equity investments. To gain a deeper understanding of RJFs financial health and market position, consider exploring detailed analyses available on platforms like ValueRay.
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income: 2.10b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.02 > 0.02 and ΔFCF/TA -0.98 > 1.0 |
| NWC/Revenue: -291.2% < 20% (prev -268.9%; Δ -22.33% < -1%) |
| CFO/TA 0.02 > 3% & CFO 1.75b > Net Income 2.10b |
| Net Debt (-5.30b) to EBITDA (2.84b): -1.87 < 3 |
| Current Ratio: 0.31 > 1.5 & < 3 |
| Outstanding Shares: last quarter (201.4m) vs 12m ago -3.73% < -2% |
| Gross Margin: 88.50% > 18% (prev 0.86%; Δ 8764 % > 0.5%) |
| Asset Turnover: 18.57% > 50% (prev 18.53%; Δ 0.05% > 0%) |
| Interest Coverage Ratio: 1.10 > 6 (EBITDA TTM 2.84b / Interest Expense TTM 1.79b) |
Altman Z'' -2.56
| A: -0.52 (Total Current Assets 21.23b - Total Current Liabilities 67.49b) / Total Assets 88.76b |
| B: 0.16 (Retained Earnings 14.05b / Total Assets 88.76b) |
| C: 0.02 (EBIT TTM 1.97b / Avg Total Assets 85.52b) |
| D: 0.18 (Book Value of Equity 13.71b / Total Liabilities 76.19b) |
| Altman-Z'' Score: -2.56 = D |
Beneish M -2.97
| DSRI: 1.03 (Receivables 4.45b/4.16b, Revenue 15.88b/15.24b) |
| GMI: 0.97 (GM 88.50% / 86.05%) |
| AQI: 1.04 (AQ_t 0.75 / AQ_t-1 0.72) |
| SGI: 1.04 (Revenue 15.88b / 15.24b) |
| TATA: 0.00 (NI 2.10b - CFO 1.75b) / TA 88.76b) |
| Beneish M-Score: -2.97 (Cap -4..+1) = A |
What is the price of RJF shares?
Over the past week, the price has changed by -2.12%, over one month by -6.65%, over three months by -3.86% and over the past year by +8.63%.
Is RJF a buy, sell or hold?
- StrongBuy: 2
- Buy: 2
- Hold: 10
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the RJF price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 184.8 | 18.3% |
| Analysts Target Price | 184.8 | 18.3% |
RJF Fundamental Data Overview March 05, 2026
P/E Forward = 12.9702
P/S = 2.1358
P/B = 2.4365
P/EG = 0.9464
Revenue TTM = 15.88b USD
EBIT TTM = 1.97b USD
EBITDA TTM = 2.84b USD
Long Term Debt = 4.22b USD (from longTermDebt, last quarter)
Short Term Debt = 368.0m USD (from shortTermDebt, last quarter)
Debt = 4.59b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -5.30b USD (from netDebt column, last quarter)
Enterprise Value = 25.06b USD (30.36b + Debt 4.59b - CCE 9.89b)
Interest Coverage Ratio = 1.10 (Ebit TTM 1.97b / Interest Expense TTM 1.79b)
EV/FCF = 16.13x (Enterprise Value 25.06b / FCF TTM 1.55b)
FCF Yield = 6.20% (FCF TTM 1.55b / Enterprise Value 25.06b)
FCF Margin = 9.78% (FCF TTM 1.55b / Revenue TTM 15.88b)
Net Margin = 13.21% (Net Income TTM 2.10b / Revenue TTM 15.88b)
Gross Margin = 88.50% ((Revenue TTM 15.88b - Cost of Revenue TTM 1.83b) / Revenue TTM)
Gross Margin QoQ = 89.44% (prev 88.64%)
Tobins Q-Ratio = 0.28 (Enterprise Value 25.06b / Total Assets 88.76b)
Interest Expense / Debt = 9.61% (Interest Expense 441.0m / Debt 4.59b)
Taxrate = 22.66% (165.0m / 728.0m)
NOPAT = 1.52b (EBIT 1.97b * (1 - 22.66%))
Current Ratio = 0.31 (Total Current Assets 21.23b / Total Current Liabilities 67.49b)
Debt / Equity = 0.37 (Debt 4.59b / totalStockholderEquity, last quarter 12.57b)
Debt / EBITDA = -1.87 (Net Debt -5.30b / EBITDA 2.84b)
Debt / FCF = -3.41 (Net Debt -5.30b / FCF TTM 1.55b)
Total Stockholder Equity = 12.39b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.45% (Net Income 2.10b / Total Assets 88.76b)
RoE = 16.94% (Net Income TTM 2.10b / Total Stockholder Equity 12.39b)
RoCE = 11.83% (EBIT 1.97b / Capital Employed (Equity 12.39b + L.T.Debt 4.22b))
RoIC = 9.58% (NOPAT 1.52b / Invested Capital 15.86b)
WACC = 9.71% (E(30.36b)/V(34.95b) * Re(10.06%) + D(4.59b)/V(34.95b) * Rd(9.61%) * (1-Tc(0.23)))
Discount Rate = 10.06% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -2.94%
[DCF] Terminal Value 62.89% ; FCFF base≈1.83b ; Y1≈1.20b ; Y5≈548.3m
[DCF] Fair Price = 68.91 (EV 8.28b - Net Debt -5.30b = Equity 13.58b / Shares 197.1m; r=9.71% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: 81.12 | EPS CAGR: 17.75% | SUE: -0.39 | # QB: 0
Revenue Correlation: 96.57 | Revenue CAGR: 12.21% | SUE: 0.54 | # QB: 0
EPS next Quarter (2026-06-30): EPS=3.02 | Chg7d=+0.000 | Chg30d=-0.007 | Revisions Net=+5 | Analysts=10
EPS current Year (2026-09-30): EPS=12.11 | Chg7d=+0.000 | Chg30d=+0.011 | Revisions Net=+2 | Growth EPS=+13.6% | Growth Revenue=+11.1%
EPS next Year (2027-09-30): EPS=13.76 | Chg7d=+0.000 | Chg30d=+0.032 | Revisions Net=+6 | Growth EPS=+13.6% | Growth Revenue=+8.0%
[Analyst] Revisions Ratio: +0.71 (6 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 3.4% (Discount Rate 10.1% - Earnings Yield 6.6%)
[Growth] Growth Spread = +12.2% (Analyst 15.7% - Implied 3.4%)